Motor nerve decline does not underlie muscle weakness in type 2 diabetic neuropathy

Muscle and Nerve

Volumn 44, Issue 2, 2011, Pages 241-245

  Herman Ijzerman, T ^a   Schaper, Nicolaas C ^b   Melai, Tom ^a,c   Blijham, Paul ^d   Meijer, Kenneth ^a   Willems, PAUL J B ^a   Savelberg, Hans H C M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c FONTYS UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diabetes; Electromyography; Muscle strength; Nerve function; Polyneuropathy

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ANKLE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEUROPATHY; DIET RESTRICTION; DYNAMOMETRY; ELECTROMYOGRAM; ELECTROPHYSIOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISOMETRIC EXERCISE; LEG; MALE; MOTOR DYSFUNCTION; MOTOR NERVE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NERVE POTENTIAL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; TORQUE;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; MUSCLE CONTRACTION; MUSCLE WEAKNESS; NERVE DEGENERATION; SENSORY RECEPTOR CELLS;

EID: 79960474658     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22039     Document Type: Article

References (21)

1. Orr R, Tsang T, Lam P, Comino E, Singh MF. Mobility impairment in type 2 diabetes: association with muscle power and effect of Tai Chi intervention. Diabetes Care 2006;29:2120-2122.
2. Volpato S, Ferrucci L, Blaum C, Ostir G, Cappola A, Fried LP, et al. Progression of lower-extremity disability in older women with diabetes: the Women's Health and Aging Study. Diabetes Care 2003;26:70-75.
3. Maty SC, Fried LP, Volpato S, Williamson J, Brancati FL, Blaum CS. Patterns of disability related to diabetes mellitus in older women. J Gerontol A Biol Sci Med Sci 2004;59:148-153.
4. Park SW, Goodpaster BH, Strotmeyer ES, de Rekeneire N, Harris TB, Schwartz AV, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 2006;55:1813-1818.
5. Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care 2007;30:1507-1512.
6. Kumar S, Ashe HA, Parnell LN, Fernando DJ, Tsigos C, Young RJ, et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994;11:480-484.
7. Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Diabetologia 1998;41:1263-1269.
8. Andreassen CS, Jakobsen J, Andersen H. Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes 2006;55:806-812.
9. Andersen H, Gadeberg PC, Brock B, Jakobsen J. Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study. Diabetologia 1997;40:1062-1069.
10. Valk GD, de Sonnaville JJ, van Houtum WH, Heine RJ, van Eijk JT, Bouter LM, et al. The assessment of diabetic polyneuropathy in daily clinical practice: reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination. Muscle Nerve 1997;20:116-118.
11. Dumitru D, Amato A, Zwarts M, editors. Electrodiagnostic medicine. Vol. 2. Philadelphia: Hanley & Belfus; 2002.
12. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve 2010;42:157-164.
13. Meijer JW, Bosma E, Lefrandt JD, Links TP, Smit AJ, Stewart RE, et al. Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes Care 2003;26:697-701.
14. Kiziltan ME, Gunduz A, Kiziltan G, Akalin MA, Uzun N. Peripheral neuropathy in patients with diabetic foot ulcers: clinical and nerve conduction study. J Neurol Sci 2007;258:75-79.
15. Phielix E, Schrauwen-Hinderling VB, Mensink M, Lenaers E, Meex R, Hoeks J, et al. Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 2008;57:2943-2949.
16. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51: 2944-2950.
17. Kuwabara S, Ogawara K, Hattori T, Suzuki Y, Hashimoto N. The acute effects of glycemic control on axonal excitability in human diabetic nerves. Intern Med 2002;16:41:360-365.
18. Kitano Y, Kuwabara S, Misawa S, Ogawara K, Kanai K, Kikkawa Y, et al. The acute effects of glycemic control on axonal excitability in human diabetics. Ann Neurol 2004;56:462-467.
19. Ramamurthy B, Hook P, Jones AD, Larsson L. Changes in myosin structure and function in response to glycation. FASEB J 2001;15: 2415-2422.
20. Vivodtzev I, Flore P, Levy P, Wuyam B. Voluntary activation during knee extensions in severely deconditioned patients with chronic obstructive pulmonary disease: benefit of endurance training. Muscle Nerve 2008;37:27-35.
21. Low PA, Benrud-Larson LM, Sletten DM, Opfer-Gehrking TL, Weigand SD, O'Brien PC, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care 2004;27:2942-2947.